Clinical Trial Update: Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen [Phase 3]

View source ↗

Summary

This Phase 3 study from Sinovac evaluates the immunogenicity and safety of a serum-free vero cell–based rabies vaccine in a simulated post-exposure prophylaxis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies vaccine (Serum-free Vero Cell)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Rabies (Healthy Volunteers) | Phase 3 | Status: NOT_YET_RECRUITING